Max Planck Society

Ukraine recap: Zelensky's defiant new year speech foreshadows tough 2024 as government tightens conscription laws

Retrieved on: 
星期四, 一月 4, 2024

Ukraine advances, Ukraine overcomes the path.

Key Points: 
  • Ukraine advances, Ukraine overcomes the path.
  • He said: “Ukrainians will cope with any energy shortage as they have no shortage of resilience and courage.
  • We defeated the darkness.” He took time to thank the Ukrainian people, talking up the country’s unity in the face of existential threat.
  • A refugee or a citizen?” The cold hard fact is that 2023 ended badly on the battlefield for Ukraine.
  • As late as the beginning of December Russia announced it was calling up another 170,000 troops.
  • In the meantime, a raft of new economic measures will increase the tax burden on ordinary Ukrainians, while at the same time radically reducing public spending.
  • Read more:
    Ukraine war increasingly seen as 'fought by the poor’, as Zelensky raises taxes and proposes strict mobilisation laws
  • You can also subscribe to our fortnightly recap of expert analysis of the conflict in Ukraine.
  • James Horncastle, of Simon Fraser University in British Columbia, meanwhile, believes that while Ukraine has suffered setbacks over the past six months or so, it can still prevail.
  • And then works out exactly what it will take in terms of western military aid to achieve that initial goal.

Do they know it’s Christmas?

  • Accordingly Ukrainians celebrated Easter and other important religious festivals and saints days at different times as well.
  • But in May 2023, the Ukrainian government took the decision to adopt the revised Julian – what we know as the Gregorian – calendar.
  • As Hann reports, the old religious calendar survived the Soviet era, but has now been swept away by decree from Kyiv.

Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors

Retrieved on: 
星期一, 十二月 18, 2023

"We are delighted to welcome Peter to Enterome's Board of Directors," said Dr. Pierre Bélichard, Chief Executive Officer of Enterome.

Key Points: 
  • "We are delighted to welcome Peter to Enterome's Board of Directors," said Dr. Pierre Bélichard, Chief Executive Officer of Enterome.
  • "Peter is a recognized leader in the biotech industry and his extensive experience in corporate strategy and drug development will be invaluable to Enterome’s future growth and success.
  • I’d also like to thank Roger for his invaluable contributions to Enterome during his time on the Board."
  • Dr. Hirth possesses a wealth of experience and an exceptional track record in the biopharmaceutical industry.

Proxygen Announces Formation of Scientific Advisory Board

Retrieved on: 
星期三, 十一月 15, 2023

VIENNA, Austria, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s scientific advisory board (SAB). The newly appointed SAB, which is comprised of highly regarded thought leaders in the emerging field of protein degradation, will offer scientific expertise and guidance to Proxygen as the company works to advance its internal molecular glue degrader programs toward clinical development. In addition to its internal programs, Proxygen is also actively engaged in strategic research collaboration and license agreements with Merck & Co (known as MSD outside the U.S. and Canada), Boehringer Ingelheim and Merck KGaA designed to jointly identify and develop novel molecular glue degraders.

Key Points: 
  • SAB Comprised of Pioneers in the Field of Protein Degradation, Including Unique Expertise in Roles of Ubiquitin Biology and Translational Medicine
    VIENNA, Austria, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s scientific advisory board (SAB).
  • Schulman and Draetta to the Proxygen team as key advisors and pair them with Drs.
  • Winter and Kubicek, who co-founded the company, based on their trailblazing research at CeMM,” said Bernd Boidol, Ph.D., chief executive officer of Proxygen.
  • By streamlining and fully integrating cutting-edge genomic, proteomic, and biochemical technologies, Proxygen has successfully developed a highly versatile glue degrader discovery engine.

Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drug

Retrieved on: 
星期一, 十二月 11, 2023

JERUSALEM, Dec. 11, 2023 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, is pleased to announce the publication following peer-review of an article titled "Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters" in the prestigious scientific journal Antiviral Research.

Key Points: 
  • The Antiviral Research paper covers several aspects of the NanoAbs, including their structure, mechanism of action, neutralization of a wide range of SARS-CoV-2 variants including Omicron, production in yeast, and formulation into aerosols.
  • "Our next pipeline project is an anti-IL-17 NanoAb for the treatment of autoimmune diseases such as plaque psoriasis and psoriasis arthritis.
  • Amir Reichman, CEO of Scinai, added "The publication of this prestigious journal article comes at an auspicious time for our company.
  • It is currently undergoing copyediting and typesetting and will soon be updated with the final version at this same link.

Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List

Retrieved on: 
星期三, 十一月 15, 2023

LONDON, Nov. 15, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research.

Key Points: 
  • Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,849 Highly Cited Researchers in 2023, from more than 1,300 institutions in 67 nations and regions.
  • Bar Veinstein, President of Academia & Government at Clarivate said: "We celebrate the Highly Cited Researchers whose contributions transform our world by helping to make it healthier, more sustainable and more secure.
  • This year the evaluation and selection process for Highly Cited Researchers has evolved as we respond to a rise in threats to research integrity.
  • ISI analysts first reviewed Highly Cited Papers™ from the last decade to create a list of preliminary candidates.

Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List

Retrieved on: 
星期三, 十一月 15, 2023

LONDON, Nov. 15, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research.

Key Points: 
  • Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,849 Highly Cited Researchers in 2023, from more than 1,300 institutions in 67 nations and regions.
  • Bar Veinstein, President of Academia & Government at Clarivate said: "We celebrate the Highly Cited Researchers whose contributions transform our world by helping to make it healthier, more sustainable and more secure.
  • This year the evaluation and selection process for Highly Cited Researchers has evolved as we respond to a rise in threats to research integrity.
  • ISI analysts first reviewed Highly Cited Papers™ from the last decade to create a list of preliminary candidates.

Nobel Laureate Hartmut Michel Joins Verseon's Scientific Advisory Board

Retrieved on: 
星期四, 十一月 9, 2023

FREMONT, Calif., Nov. 9, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board. Dr. Michel's work in X-ray crystallography established methodologies for crystallizing cellular membrane proteins and elucidating their structures.

Key Points: 
  • FREMONT, Calif., Nov. 9, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board.
  • Dr. Michel is a recipient of the Biophysics Prize of the American Physical Society and is one of the original eleven recipients of the Gottfried Wilhelm Leibniz Prize , the highest honor awarded in German scientific research.
  • Verseon's team is excited to have Dr. Michel join the company's scientific advisory board.
  • We are honored to have him on our advisory board."

The 6th WLA Forum Ends with Strong Call for Global Scientific Cooperation

Retrieved on: 
星期四, 十一月 9, 2023

At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.

Key Points: 
  • At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.
  • Some really touching and inspiring moments happened during the attention-drawing WLA SHE Forum, which were encouraging for more females to bravely pursuing the scientific ambitions.
  • and Angela Chan Distinguished Chair in Energy and Professor of Chemistry at UC Berkeley emphasized the importance of scientific cooperation to address the global issues.
  • The 7th WLA Forum will take place in 2024 and the nomination for the 2024 WLA Prize will kick off soon.

The 6th WLA Forum Ends with Strong Call for Global Scientific Cooperation

Retrieved on: 
星期四, 十一月 9, 2023

At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.

Key Points: 
  • At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.
  • Some really touching and inspiring moments happened during the attention-drawing WLA SHE Forum, which were encouraging for more females to bravely pursuing the scientific ambitions.
  • and Angela Chan Distinguished Chair in Energy and Professor of Chemistry at UC Berkeley emphasized the importance of scientific cooperation to address the global issues.
  • The 7th WLA Forum will take place in 2024 and the nomination for the 2024 WLA Prize will kick off soon.

Noster research: NOSTER and Science Microbiome Prize Symposium and Award Ceremony Honor Young Researchers' Novel Contributions

Retrieved on: 
星期四, 十月 26, 2023

KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.

Key Points: 
  • KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.
  • The NOSTER & Science Microbiome Prize rewards innovative research from young investigators studying how microbiota has the potential to contribute to our understanding of health and disease, or to guide novel therapeutic interventions.
  • The Japanese company NOSTER established this award in 2020 in partnership with Science and its publisher, the American Association for the Advancement of Science (AAAS).
  • NOSTER remains committed to supporting young scientists through this award and aims to contribute to breakthrough drug development driven by microbiome research.